This policy outlines the procedure to be followed if a bloodborne pathogen exposure occurs. Copies of this plan MUST be given to all students. Students MUST read this policy when they enroll in a CCRI health program, and MUST sign the waiver of understanding that they understand CCRI's policy on bloodborne pathogen exposure response and its medical and financial implications.
Medical procedures to be followed in case of exposure are taken from CDC guidelines. Whatever the site of the exposure incident and treatment, CDC guidelines should be followed and the following testing should be done: The source patient‘s and the exposure recipient‘s blood should be tested as soon as possible for anti-HBsAG, anti-HCV and anti-HIV. The exposure recipient should be tested for anti-HBsAG, anti-HCV and anti-HIV the same day as the exposure to provide baseline data. Liver function tests should be obtained. Hepatitis B testing is not required if the exposure recipient has received the hepatitis B vaccine and was post-tested to prove seroconversion immunity. The exposure recipient should receive counseling concerning the signs and symptoms associated with anti-HIV seroconversion and given the opportunity for further clinical evaluation. The health care provider at the chosen treatment site should be asked to determine whether to give information on AZT or other prophylaxis. Exposure includes the following.
At present CCRI does not require its students to carry health insurance. This policy is currently under review. CCRI urges all its uninsured students, particularly those in CCRI health programs, to purchase insurance that will provide, in particular, adequate coverage in case of a bloodborne exposure incident. CCRI urges all insured students to consult their insurance providers to determine their coverage limits, especially coverage for the blood tests that may be required following a bloodborne pathogen exposure.